Prudent investors ought to pay attention to a menacing pattern developing in the stock market. Please click here for an annotated chart. The chart is of the Nasdaq 100 ETF QQQ, A similar pattern can be seen in S&P 500 ETF SPY, I picked QQQ because the pattern is more
Donald Trump is starting his first full week as U.S. president. Bearish investors have been out in full force, proclaiming, with high confidence, that it’s time to sell stocks. At the same time, bullish gurus are saying just the opposite. So who’s right? Let’s explore the answer. First, we need
In 1971, a Japanese biochemist, Akira Endo, started work on what turned out to be the next big thing in the prevention of heart attacks and strokes, known as statins. In 1978, Merck (MRK) isolated lovastatin from fungusAspergillus terreus. Lovastatin is naturally contained in red yeast rice, a traditional Chinese fermented rice
Consider scaling out more $AMGN right here around $56.42 www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning
We have been short on $AMGN. Details in the earnings report prove our thesis to be correct. However in view of the generally bullish market, we suggest taking partial profits right here at $56.92 and tightening the stop band on the rest. Consider exiting the position by scaling out. www.thearorareport.com
We aggressively sold short $AMGN yesterday at $60.80 as per our plan in the earlier post. We take no issue with the positive trial results. Our issue is with the earning estimates of the street. Majority of $AMGN earnings come from anemia drugs. We continue to believe that these earnings
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
President Obama in his speech before AMA specifically mentioned generic biologics and anemia drugs. We sold short AMGN around $49.90 and BBH around $90.30. Consider adding to the positions based on technicals. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE